UCLA Campus    |   UCLA Health    |   School of Medicine Translate:
UCLA Health It Begins With U

Sanaz Memarzadeh, MD, PhD

Print
Email

Sanaz Memarzadeh, MD, PhD

UCLA Physician Sanaz Memarzadeh, MD, PhD specializes in Gynecologic Oncology, Obstetrics & Gynecology.
Specialty
Gynecologic Oncology, Obstetrics & Gynecology
Gender
Female
Language Spoken
English, Farsi, Spanish (medical)
Hospital Affiliation
Ronald Reagan UCLA Medical Center
State License Number
A65689
Contact
(310) 794-7274 Appointments
(310) 794-9098 Gyn oncology office
(310) 206-8918 Laboratory
Fax Number
(310) 794-9110
PRACTICE LOCATION

200 Medical Plaza, Suite 220
Box 6928
Los Angeles, Ca 90095-6928

MEDICAL BOARD CERTIFICATION
Gynecologic Oncology, American Board of Obstetrics and Gynecology, 2008, 2011
Obstetrics & Gynecology, American Board of Obstetrics and Gynecology, 2005, 2011
EDUCATION
Fellowship
Gynecologic Oncology, UCLA School of Medicine, 2000 - 2003
Residency
Obstetrics & Gynecology, UCLA School of Medicine, 1997 - 2000
Internship
Obstetrics & Gynecology, UCLA School of Medicine, 1996 - 1997
Medical Degree
MD, University of Pittsburgh School of Medicine, 1996
CLINICAL INTEREST
Cervical Cancer, Endometrial Cancer, Gestational Trophoblastic Disease, Gynecologic Cancer Surgery, Gynecologic Endoscopic and Laparoscopic Surgery for Ovarian Cysts and Fibroids, Ovarian Cancer, Pre-invasive Diseases of Vulva, Vagina and Cervix, Robotic Surgery for Gynecologic Cancers and Benign Gynecology, Vaginal Cancer, Vulvar Cancer
AFFILIATION
MORE INFORMATION
Additional Information

BIO
Dr. Sanaz Memarzadeh is a board certified gynecologic oncologist. She specializes in the prevention, diagnosis and treatment of all gynecologic pre-invasive and invasive diseases. She has completed her residency at the UCLA medical Center. After the conclusion of her formal residency, she completed a three year fellowship training in gynecologic oncology at the UCLA Medical Center. This fellowship is designed to meet the subspecialty requirements of the Gynecologic Oncology Division of the American Board of Obstetrics and Gynecology and functions in concert with the Gynecologic Oncology Divisions at Cedars-Sinai and Kaiser Permanente. This fellowship has provided her with advanced surgical training for treatment of gynecologic cancers in addition to training in administration of chemotherapy and care for cancer patients.

Following her fellowship, Dr. Memarzadeh completed a Ph.D. in the department of Molecular Biology at UCLA. Dr. Memarzadeh performs basic science research at UCLA focusing on molecular pathways that lead to the development of gynecologic cancers. She has won multiple awards including the Reproductive Scientist Developmental Grant, the Ovarian Cancer Research Foundation Grant and a Gynecologic Cancer Foundation award. Dr. Memarzadeh has authored many published articles in respected journals and textbook chapters.

Dr. Memarzadeh currently maintains staff and operating room privileges at UCLA Westwood. She is accepting new patients seeking care in all aspects of gynecologic cancer or pre-cancerous diseases.

ADDITIONAL EDUCATION

  • PhD in Molecular Biology, UCLA, 2008

RESEARCH INTERESTS
Dr. Sanaz Memarzadeh’s research in her laboratory, focuses on two poorly understood and under studied epithelial gynecologic malignancies endometrial and ovarian carcinoma. Even though both cancer subtypes pose a serious health risk to women little is known about what cells give rise to each tumor subtype, how these tumors initiate and strategies for targeted therapy.  The goal of the laboratory is to identify ovarian and endometrial cancer initiating cells and targeting genetic pathways essential for their survival as part of the treatment for these gynecologic cancers. The G.O. Discovery team hypothesizes that the normal stem cells in the endometrium or ovary/fallopian tube could be the target cell for formation of endometrial or ovarian papillary serous carcinoma respectively.  The normal epithelial stem of these gynecologic organs may also be precursors for ovarian and endometrial cancer stem cells.  The lab aims to pinpoint the genetic changes that prompt normal gynecologic epithelial cells to convert into cancer cells and identify the chemical and biologic molecules that can be used to stop their growth. Such new therapies could be better tolerated with less side effects and better chances of eradicating these women’s cancers.

Lab website: www.godiscoverylab.com

Back to top
Referring a Patient to UCLA
Our staff will assist you in selecting the appropriate UCLA clinical department for your patient.

Find out how to refer a patient
Dr. Sanaz Memarzadeh,  click here to update your profile.